These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 30684913)
1. Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis. Andrés Cerezo L; Hulejová H; Šumová B; Kropáčková T; Kryštůfková O; Klein M; Mann HF; Zámečník J; Pecha O; Pavelka K; Vencovský J; Šenolt L Cytokine; 2019 Apr; 116():13-20. PubMed ID: 30684913 [TBL] [Abstract][Full Text] [Related]
2. The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies. Pleštilová L; Mann H; Andrés Cerezo L; Pecha O; Vencovský J; Šenolt L Arthritis Res Ther; 2014 Oct; 16(5):468. PubMed ID: 25359220 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-35 in idiopathic inflammatory myopathies. Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920 [TBL] [Abstract][Full Text] [Related]
4. Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis. Andrés Cerezo L; Šumová B; Prajzlerová K; Veigl D; Damgaard D; Nielsen CH; Pavelka K; Vencovský J; Šenolt L Arthritis Res Ther; 2017 Apr; 19(1):79. PubMed ID: 28446208 [TBL] [Abstract][Full Text] [Related]
5. Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis. Wu S; Peng W; Zhang Y; Guo J; Fu J; Wang W J Transl Med; 2019 Dec; 17(1):420. PubMed ID: 31842908 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires. Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700 [TBL] [Abstract][Full Text] [Related]
8. Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity. Fornaro M; Girolamo F; Cacciapaglia F; Carabellese G; Bizzoca R; Scioscia C; Coladonato L; Lopalco G; Ruggieri M; Mastrapasqua M; Fari G; D'Abbicco D; Iannone F Clin Exp Immunol; 2023 Dec; 214(1):94-102. PubMed ID: 37280166 [TBL] [Abstract][Full Text] [Related]
9. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis. Mandel DE; Malemud CJ; Askari AD Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083 [TBL] [Abstract][Full Text] [Related]
10. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies. Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950 [TBL] [Abstract][Full Text] [Related]
11. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects]. Eymard B Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270 [TBL] [Abstract][Full Text] [Related]
12. Polymyositis and dermatomyositis - challenges in diagnosis and management. Yang SH; Chang C; Lian ZX J Transl Autoimmun; 2019 Dec; 2():100018. PubMed ID: 32743506 [TBL] [Abstract][Full Text] [Related]
13. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Mammen AL Ann N Y Acad Sci; 2010 Jan; 1184():134-53. PubMed ID: 20146695 [TBL] [Abstract][Full Text] [Related]
14. Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features. Stenzel W; Goebel HH; Aronica E Neuropathol Appl Neurobiol; 2012 Dec; 38(7):632-46. PubMed ID: 22989019 [TBL] [Abstract][Full Text] [Related]
15. Polymyositis: an overdiagnosed entity. van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190 [TBL] [Abstract][Full Text] [Related]
16. Resistin in idiopathic inflammatory myopathies. Filková M; Hulejová H; Kuncová K; Pleštilová L; Cerezo LA; Mann H; Klein M; Zámečník J; Gay S; Vencovský J; Senolt L Arthritis Res Ther; 2012 May; 14(3):R111. PubMed ID: 22577940 [TBL] [Abstract][Full Text] [Related]
17. The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies. Cerezo LA; Kuncová K; Mann H; Tomcík M; Zámecník J; Lukanidin E; Neidhart M; Gay S; Grigorian M; Vencovsky J; Senolt L Rheumatology (Oxford); 2011 Oct; 50(10):1766-72. PubMed ID: 21712367 [TBL] [Abstract][Full Text] [Related]
18. [Clinical and immunological characteristics of 88 cases of overlap myositis]. Xiao YS; Zhu FY; Luo L; Xing XY; Li YH; Zhang XW; Shen DH Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1088-1093. PubMed ID: 34916687 [TBL] [Abstract][Full Text] [Related]
19. Correlation between serum levels of IL-15 and IL-17 in patients with idiopathic inflammatory myopathies. Notarnicola A; Lapadula G; Natuzzi D; Lundberg IE; Iannone F Scand J Rheumatol; 2015 May; 44(3):224-8. PubMed ID: 25379698 [TBL] [Abstract][Full Text] [Related]